Gujrathi Sheila (CIK 1575202) reported 2 SEC Form 4 insider transactions across 2 companies over the past 18 months (most recent 2026-03-04). Recent activity: Sell VTYX (130,000 shares), Buy JANX (3,750 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-03-04 | Ventyx Biosciences, Inc. (VTYX) | Director | Sell | 130,000 | $0 |
| 2025-06-13 | Janux Therapeutics, Inc. (JANX) | Director | Buy | 3,750 | $0 |
Source: SEC Form 4 filings · as of 2026-03-04